Elite Pharmaceuticals (ELTP) Revenue (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported Revenue of $32.36 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 19.5% from $40.21 million a year earlier and down 20.6% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Revenue came in at $141.01 million, up 33.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $148.87 million, up 77.1% from FY2025.
- Revenue has increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 42.4% (FY2021 to FY2026).
- By fiscal year, Revenue came in at $84.04 million in FY2025 (+48.4%), $56.63 million in FY2024 (+65.8%), $34.16 million in FY2023 (+5.9%) and $32.26 million in FY2022 (+27.1%).
- Five-year quarterly Revenue spans a low of $7.67 million in fiscal Q4 2022 and a high of $40.75 million in fiscal Q4 2026.
- Year over year, Revenue gained in six of the last eight quarters, with growth averaging 54.8%.
- The high point for year-over-year Revenue in five years was fiscal Q3 2026 (growth of 119.9%); the low point was fiscal Q1 2027 (a decline of 19.5%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $40.75 million (Q4 2026), $31.59 million (Q3 2026) and $36.32 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,159.63 Bn | 1,128.22 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 627.73 Bn | 546.26 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 511.44 Bn | 484.55 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.62 Bn | 321.00 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 296.61 Bn | 260.60 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.13 Bn | 234.81 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 193.41 Bn | 167.61 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.25 Bn | 117.90 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Elite Pharmaceuticals | 269.31 Mn | 150.98 Mn | 13.51 Mn | 32.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.36 Mn |
| Mar 31, 2026 | 40.75 Mn |
| Dec 31, 2025 | 31.59 Mn |
| Sep 30, 2025 | 36.32 Mn |
| Jun 30, 2025 | 40.21 Mn |
| Mar 31, 2025 | 32.00 Mn |
| Dec 31, 2024 | 14.36 Mn |
| Sep 30, 2024 | 18.88 Mn |
| Jun 30, 2024 | 18.80 Mn |
| Mar 31, 2024 | 17.95 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 14.16 Mn |
| Jun 30, 2023 | 8.98 Mn |
| Mar 31, 2023 | 8.64 Mn |
| Dec 31, 2022 | 9.25 Mn |
| Sep 30, 2022 | 8.59 Mn |
| Jun 30, 2022 | 7.67 Mn |
| Mar 31, 2022 | 7.67 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 8.56 Mn |
API Access
Elite Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();